Morgan Stanley GIFT and Harrington Discovery Institute Awarded for Impactful Collaboration in Medical Advancements

Morgan Stanley GIFT and Harrington Discovery Institute Receive the Synergy for Change Award

At the recent 2024 Donor Advised Funds (DAF) Giving Summit held in Nashville, Tennessee, a significant recognition was awarded to the partnership between Morgan Stanley GIFT Cures and the Harrington Discovery Institute. This prestigious Synergy for Change Award is intended to celebrate collaboration between for-profit and non-profit entities that lead to greater societal benefits than either could achieve independently.

The Synergy for Change Award highlights remarkable efforts to expedite treatment advancements for intricate diseases, notably Alzheimer's, cancer, and rare conditions. This collaboration embodies a modern approach to philanthropy, demonstrating how collective power can combat pressing health challenges.

The DAF Giving Summit serves as a platform to modernize charitable giving, featuring innovative technologies and best practices to foster impactful contributions. Among its accomplishments, the summit recognizes leaders driving significant innovation in philanthropy, highlighting the collaborative spirit essential for initiating medical breakthroughs and revolutionizing patient outcomes.

Morgan Stanley GIFT Cures℠, established in 2019, represents the inaugural special interest program of the Morgan Stanley Global Impact Funding Trust. Its foundation arose from clients' desires for transparent and impactful results in their philanthropic pursuits related to disease research. This unique program enables philanthropists and organizations to ignite transformative treatments and facilitate market introductions by strategically combining resources to amplify the effects of their giving.

Dr. Jonathan Stamler, President, and co-founder of the Harrington Discovery Institute, expressed gratitude for the recognition, stating, "We are honored to receive this award, which underscores the critical role philanthropy plays in advancing science to create new medicines for patients in need. Through partnerships like Morgan Stanley GIFT Cures, we transform philanthropy into a catalyst for change—bridging the divide between scientific discoveries and life-saving treatments. Our collaboration empowers donors to enhance the impact of their contributions, generating breakthroughs that meet urgent needs and translate hope into tangible cures."

Melanie Schnoll Begun, Head of Family Office Resources Field Engagement and Philanthropy Management at Morgan Stanley, also emphasized the significance of the award, stating, "Receiving the Synergy for Change Award is a testament to the impact achieved through the joint efforts of Morgan Stanley GIFT Cures and the Harrington Discovery Institute. Our collaboration supports clients in their philanthropic pursuits aimed at developing treatments for diseases affecting them and their families. This initiative fosters a community of like-minded donors who gain access to a network of physician-scientists dedicated to crafting new medicines across various therapeutic areas, ultimately delivering cures to numerous individuals and families affected by illness."

The mission of Morgan Stanley GIFT Cures is to harness the strength of collective philanthropy to support the Harrington Discovery Institute's objective of transforming promising discoveries into actual medicines. With over 200 drugs in development, 71 supported institutions, the launch of 42 companies, and several key clinical candidates and pharma licenses, the collaboration continues to contribute meaningfully to the advancement of new medicines that benefit humanity.

In essence, the Synergy for Change Award represents not only a recognition of excellence but also a reaffirmation of the vital role that cohesive action plays in the realm of healthcare innovation, significantly affecting lives and inspiring a renewed hope for patients facing challenging health conditions.